Design, synthesis and biological evaluation of novel ferrocene-pyrazole derivatives containing nitric oxide donors as COX-2 inhibitors for cancer therapy
Keywords: Pyrazole; Ferrocene; COX-2 inhibitor; NO-Releasing; Anticancer;